Invesco Biotechnology & Genome ETF Rating $66.14 -1.17 (-1.74%) As of 07/11/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.68Holdings in PBE have an aggregate rating of Moderate Buy based on 368 analyst ratings issued in the past year covering 25 companies (88.3% of the portfolio).PBE Aggregate Price Target$66.14High Prediction$66.14Average Prediction$66.14Low Prediction$66.14Holdings in PBE have an aggregate price target of $66.14 and a range of $66.14 to $66.14 covering 25 companies (88.3% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.53%ILMNIllumina$99.25-0.8%4.8689 of 5 stars2.40$125.11 26.1%20Trending NewsAnalyst Downgrade5.18%ALNYAlnylam Pharmaceuticals$314.94-2.4%4.1734 of 5 stars2.80$345.70 9.8%25Positive NewsAnalyst Forecast5.14%RPRXRoyalty Pharma$35.84-0.8%4.9751 of 5 stars3.25$48.33 34.9%4Positive News5.03%VRTXVertex Pharmaceuticals$468.85-2.2%4.325 of 5 stars2.54$511.62 9.1%28Positive News4.97%AMGNAmgen$295.27-1.7%4.4424 of 5 stars2.35$307.82 4.2%23Positive News4.86%GILDGilead Sciences$109.64-4.3%4.9337 of 5 stars2.77$111.38 1.6%26Positive News4.81%BMRNBioMarin Pharmaceutical$58.10-1.2%4.9428 of 5 stars2.75$93.61 61.1%24Positive News4.47%UTHRUnited Therapeutics$295.52-1.5%4.9887 of 5 stars2.69$383.08 29.6%13Positive News3.73%AVXLAnavex Life Sciences$11.11-0.6%3.7636 of 5 stars3.33$44.00 296.0%33.28%BPMCBlueprint Medicines$129.300.0%1.2338 of 5 stars2.24$128.25 -0.8%21High Trading Volume3.14%ARWRArrowhead Pharmaceuticals$18.31-2.9%3.5857 of 5 stars2.75$43.71 138.7%8Gap Down2.94%CDNACareDx$20.13-2.4%4.1684 of 5 stars2.67$30.33 50.7%6Positive News2.88%PTGXProtagonist Therapeutics$53.00+0.3%1.5906 of 5 stars3.00$66.10 24.7%10Positive News2.82%DVAXDynavax Technologies$10.58-2.9%4.3764 of 5 stars2.50$24.00 126.8%42.80%COLLCollegium Pharmaceutical$32.52-1.5%4.2285 of 5 stars2.75$43.75 34.5%4Buyback AnnouncementGap Up2.79%QGENQiagen$48.13-0.9%3.5622 of 5 stars2.30$49.40 2.6%10High Trading Volume2.78%NBIXNeurocrine Biosciences$133.46-1.1%4.5359 of 5 stars2.87$163.91 22.8%23Trending NewsInsider TradeAnalyst Revision2.75%TGTXTG Therapeutics$37.08-1.6%3.5413 of 5 stars2.80$43.80 18.1%5Positive News2.71%RGENRepligen$130.19-2.8%4.5975 of 5 stars2.69$170.75 31.2%13Positive News2.69%INCYIncyte$68.59-2.5%4.7309 of 5 stars2.22$74.53 8.7%182.66%HALOHalozyme Therapeutics$57.15-0.8%4.8275 of 5 stars2.17$62.50 9.4%122.63%FOLDAmicus Therapeutics$6.09-3.3%4.127 of 5 stars2.70$16.22 166.4%10Analyst Revision2.61%EXELExelixis$44.86-0.7%4.786 of 5 stars2.48$44.72 -0.3%212.60%PTCTPTC Therapeutics$48.55-2.0%4.5605 of 5 stars2.67$65.00 33.9%15Positive News2.50%EXASExact Sciences$51.91-2.6%4.7587 of 5 stars2.95$70.50 35.8%22 This page (NYSEARCA:PBE) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBE Stock Alerts